Generic Oncology Drugs Market Overview 2024-2033 – Share, Size, Insights, Forecast

Overview and Scope Generic oncology drugs refer to cancer medications produced by different pharmaceutical companies when the patent protection of the original brand-name drug is expired. These drugs contain the same active ingredients and have the same dosage forms, strength, route of administration, and intended use as the original brand-name drug. Sizing and Forecast The generic oncology drugs market size has grown strongly in recent years. It will grow from $25.64 billion in 2023 to $27.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%.  The  growth in the historic period can be attributed to patent expirations, healthcare cost containment, increased cancer prevalence, health insurance coverage, physician prescribing practices. The generic oncology drugs market size is expected to see strong growth in the next few years. It will grow to $35.54 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.  The growth in the forecast period can be attributed to biosimilar approvals, increased competition, telemedicine and remote care, tailored treatment paradigm, pricing pressure. Major trends in the forecast period include increased pharmacovigilance, regulatory streamlining, combination therapy focus, precision generic oncology medications, expanded market access. To access more details regarding this report, visit the link: https://www.thebusinessresearchcompany.com/report/generic-oncology-drugs-global-market-report Segmentation & Regional Insights The generic oncology drugs market covered in this report is segmented – 1) By Molecule Type: Large Molecule, Small Molecule 2) By Route of Administration: Oral, Parenteral 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Managed Care Institutions North America was the largest region in the generic oncology drugs market in 2023. The regions covered in the generic oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East,  Africa. Intrigued to explore the contents? Secure your hands-on sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=12174&type=smp Major Driver Impacting Market Growth A significant rise in cancer patients is expected to propel the growth of the generic oncology drugs market going forward. Cancer refers to uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. The availability of cost-effective generic oncology drugs plays a crucial role in cancer treatment by increasing access to essential therapies, promoting market competition, and reducing healthcare costs. For instance, in January 2022, according to the National Cancer Institute (NCI), a US-based government agency, in the United States, approximately 5.4% of the population, or 18.1 million individuals, were cancer survivors. In addition, 623,405 people were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma in 2022, projected to rise to 693,452 by 2025. Therefore, the significant rise in cancer patients is driving the growth of the generic oncology drugs market. Key Industry Players Major companies operating in the generic oncology drugs market report are Pfizer Inc., AbbVie, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Fresenius Kabi AG, GlaxoSmithKline PLC, Eli Lilly and Company, Merck & Co. Inc., Becton Dickinson and Company, Baxter International Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Hikma Pharmaceuticals, Endo Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Lupin Limited, Towa Pharmaceutical Co Ltd, Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Accord Healthcare The generic oncology drugs market report table of contents includes: 1. Executive Summary 2. Generic Oncology Drugs Market Characteristics 3. Generic Oncology Drugs Market Trends And Strategies 4. Generic Oncology Drugs Market - Macro Economic Scenario 5. Global Generic Oncology Drugs Market Size and Growth … 32. Global Generic Oncology Drugs Market Competitive Benchmarking 33. Global Generic Oncology Drugs Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Generic Oncology Drugs Market 35.Generic Oncology Drugs Market Future Outlook and Potential Analysis 36. Appendix Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info  Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ He